Health Catalyst Inc
| Fiscal year | Operating cash flow | Stock comp | Capex | Free cash flow | Net borrowing | FCFE | Shares (B) | FCF per share | Year-end price | FCF yield |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | -0.0 | 0.0 | 0.0 | -0.1 | +0.1 | 0.0 | 0.04 | $-1.89 | $43.53 | -4.3% |
| 2021 | -0.0 | 0.1 | 0.0 | -0.1 | +0.0 | -0.1 | 0.05 | $-2.25 | $39.62 | -5.7% |
| 2022 | -0.0 | 0.1 | 0.0 | -0.1 | +0.0 | -0.1 | 0.05 | $-2.31 | $10.63 | -21.7% |
| 2023 | -0.0 | 0.1 | 0.0 | -0.1 | +0.0 | -0.1 | 0.06 | $-1.83 | $9.26 | -19.7% |
| 2024 | 0.0 | 0.0 | 0.0 | -0.0 | -0.1 | -0.1 | 0.06 | $-0.70 | $7.07 | -9.9% |
| 2025 | 0.0 | 0.0 | 0.0 | -0.0 | +0.0 | -0.0 | 0.07 | $-0.39 | $2.39 | -16.3% |
| 5-yr CAGR | n/m | -6.6% | -37.9% | n/m | n/a | n/m | 12.1% | n/m | -44.0% | avg -12.9% |
| Fiscal year | Revenue | EBITDA | EBITDA margin | Debt incl. leases | Cash & securities | Market cap | Enterprise value | EV / EBITDA | Net debt / EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| 2020 | 0.2 | -0.1 | -41.0% | 0.2 | 0.3 | 2 | 2 | n/m | n/m |
| 2021 | 0.2 | -0.1 | -43.9% | 0.2 | 0.4 | 2 | 2 | n/m | n/m |
| 2022 | 0.3 | -0.1 | -33.2% | 0.2 | 0.4 | 1 | 0 | n/m | n/m |
| 2023 | 0.3 | -0.1 | -28.6% | 0.2 | 0.3 | 1 | 0 | n/m | n/m |
| 2024 | 0.3 | -0.0 | -9.3% | 0.2 | 0.4 | 0 | 0 | n/m | n/m |
| 2025 | 0.3 | 0.0 | 4.6% | 0.2 | 0.1 | 0 | 0 | 16.7x | 5.13x |
| 5-yr CAGR | 10.5% | n/m | avg -25.2% | -2.8% | -18.8% | -37.3% | -31.9% | median 16.7x | avg 5.13x |
Revenue grew 10.5% a year and EBITDA n/m a year from FY2020 to FY2025, and free cash flow after stock compensation did not grow from a positive base. The share count rose 12.1% a year, so per-share figures grew more slowly than the totals. Net debt stood at 5.1x EBITDA at the last fiscal year-end.
From the data: EBITDA was not positive in enough years to set a growth rate and an exit multiple, so there is no hurdle price. The share count moved 111% in FY2020 with no split on record (a merger, offering or buyback), so per-share figures before and after that year are not on one basis. The share count moved 20% in FY2021 with no split on record (a merger, offering or buyback), so per-share figures before and after that year are not on one basis.
- Free cash flow is operating cash flow less stock-based compensation less capital spending. Stock comp is treated as a real cost.
- Net borrowing is the year's change in long-term debt. FCFE adds it back to free cash flow, the classic one-page definition.
- EBITDA is operating income plus depreciation and amortization. Debt includes lease obligations; cash includes short-term investments.
- Market cap uses the fiscal year-end price as traded, restated for later splits but not for dividends; enterprise value adds debt and subtracts cash.
- Share count is the yearly change in shares outstanding over the period; flat or falling clears. Cash margin is the latest free cash flow margin against its three-year average; within two points clears.
- Hurdle price is the present value, at the hurdle rate, of ten years of modeled free cash flow per share plus a year-10 sale at the exit multiple. It is shown as an exhibit: the 2011 to 2021 back-test found that buying below it did not sort winners from losers, so it is not scored.
- Cleared on a check means the number clears the stated rule; Not cleared means it does not. Durable, Holding and First year say how many fiscal years running the company has cleared all four staying-power checks (four or more, two or three, one); Partial and Not cleared count the checks it clears today. All of it is fact about the filings, not a rating of the stock.